Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 15 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) | 5件: Digoxin Digoxin,Flurbiprofen, Midazolam, Montelukast, Omeprazole (Novo-omeprazole) | 5件: Digoxin
Digoxin
,Flurbiprofen , Omeprazole (Omeprazole), Midazolam , Montelukast 💬 1. BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)
| 25件: ATP1A1 ATP1A1,ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 25件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB ... 1. BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)
| 49件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regula ... | 1件: 46 46 💬1. BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Clartihromycin, amoxicillin, and omeprazole | 2件: Amoxicillin Amoxicillin,Omeprazole (Novo-omeprazole) | 3件: Amoxicillin
Amoxicillin
,Omeprazole (Omeprazole), Amoxicillin 💬 2. Clartihromycin, amoxicillin, and omeprazole
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 6 6 💬2. Clartihromycin, amoxicillin, and omeprazole
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Diclofenac + Omeprazole | 2件: Diclofenac Diclofenac,Omeprazole (Novo-omeprazole) | 2件: Omeprazole
Omeprazole
(Omeprazole),Diclofenac 💬 3. Diclofenac + Omeprazole
| 4件: ATP4A ATP4A,ATP4B, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemi ... | 1件: 46 46 💬3. Diclofenac + Omeprazole
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Dimebon + Omeprazole | 2件: Latrepirdine Latrepirdine,Omeprazole (Novo-omeprazole) | 2件: Omeprazole
Omeprazole
(Omeprazole),Latrepirdine 💬 4. Dimebon + Omeprazole
| 8件: ACHE ACHE,ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 4. Dimebon + Omeprazole
| 26件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | 1件: 8 8 💬4. Dimebon + Omeprazole
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Naproxen 500 mg tablets (PN 200 minus omeprazole) | 2件: Naproxen Naproxen,Omeprazole (Novo-omeprazole) | 2件: Naproxen
Naproxen
,Omeprazole (Omeprazole) 💬 5. Naproxen 500 mg tablets (PN 200 minus omeprazole)
| 4件: ATP4A ATP4A,ATP4B, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemi ... | 2件: 46 46, 271 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Omeprazole | 1件: Omeprazole Omeprazole (Novo-omeprazole) | 1件: Omeprazole
Omeprazole
(Omeprazole) 💬6. Omeprazole
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 14件: 6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 💬6. Omeprazole
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Omeprazole (UK licensed generic product) | 1件: Omeprazole Omeprazole (Novo-omeprazole) | 1件: Omeprazole
Omeprazole
(Omeprazole) 💬7. Omeprazole (UK licensed generic product)
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 85 85 💬7. Omeprazole (UK licensed generic product)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Omeprazole 20mg | 1件: Omeprazole Omeprazole (Novo-omeprazole) | 1件: Omeprazole
Omeprazole
(Omeprazole) 💬8. Omeprazole 20mg
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 51 51 💬8. Omeprazole 20mg
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Omeprazole 40 mg | 1件: Omeprazole Omeprazole (Novo-omeprazole) | 1件: Omeprazole
Omeprazole
(Omeprazole) 💬9. Omeprazole 40 mg
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 96 96 💬9. Omeprazole 40 mg
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Omeprazole 40mg Capsule | 1件: Omeprazole Omeprazole (Novo-omeprazole) | 1件: Omeprazole
Omeprazole
(Omeprazole) 💬10. Omeprazole 40mg Capsule
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 299 299 💬10. Omeprazole 40mg Capsule
|